![]() HCV-IN-29 structure
|
Common Name | HCV-IN-29 | ||
---|---|---|---|---|
CAS Number | 1009119-83-8 | Molecular Weight | 570.385 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C26H32Cl4N6 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of HCV-IN-29HCV-IN-29 is a hepatitis C virus (HCV) inhibitor exacted from patent US8329159B2, compound 1e[1]. |
Name | 5,5'-[1,1'-Biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-1H-imidazole] hydrochloride (1:4) |
---|---|
Synonym | More Synonyms |
Description | HCV-IN-29 is a hepatitis C virus (HCV) inhibitor exacted from patent US8329159B2, compound 1e[1]. |
---|---|
Related Catalog | |
References |
[1]. Makonen Belema, et al. Hepatitis C virus inhibitors. US8329159B2. |
Molecular Formula | C26H32Cl4N6 |
---|---|
Molecular Weight | 570.385 |
Exact Mass | 568.144226 |
1H-Imidazole, 5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-[(2S)-2-pyrrolidinyl]-, hydrochloride (1:4) |
T5M CNJ B- BT5MTJ& ER DR D- ET5M CNJ B- BT5MTJ &&(2S)- Form |
5,5'-[1,1'-Biphenyl]-4,4'-diylbis[2-[(2S)-2-pyrrolidinyl]-1H-imidazole hydrochloride (1:4) |
4,4'-(4,4'-Biphenyldiyl)bis{2-[(2S)-2-pyrrolidinyl]-1H-imidazole} tetrahydrochloride |
1H-IMIDAZOLE-5,5-[1,1-BIPHENYL]-4,4-DIYLBIS[2-(2S)-2-PYRROLI DINYL]HYDROCHLORIDE(1:4) |